DNLI Denali Therapeutics Inc.
$18.40
Denali Therapeutics Inc. (DNLI) Earnings News
Earnings press releases, previews and reviews for Denali Therapeutics Inc. (DNLI), newest first. Our most recent is review: Denali's AVLAYAH Launch Blows Past Guidance as Q4 Outlook Nearly Triples, but a Shrinking Stock Prices In Doubt.
Tuesday
November 3, 2026
7:23 PM ET
Denali's AVLAYAH Launch Blows Past Guidance as Q4 Outlook Nearly Triples, but a Shrinking Stock Prices In Doubt
Earnings Whispers · Review
Tuesday
November 3, 2026
4:01 PM ET
Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
Monday
October 26, 2026
8:16 PM ET
Denali Faces a Revenue Test as Shares Slide Toward Post-Earnings Lows
Earnings Whispers · Preview
Thursday
October 22, 2026
4:01 PM ET
Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026
Thursday
August 6, 2026
4:01 PM ET
Denali Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
Monday
July 27, 2026
4:01 PM ET
Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026